Eckert & Ziegler SE Stock Deutsche Boerse AG

Equities

EUZ

DE0005659700

Office Equipment

Real-time Estimate Tradegate 05:07:45 2024-04-23 am EDT 5-day change 1st Jan Change
36.44 EUR -1.78% Intraday chart for Eckert & Ziegler SE +7.33% -11.47%
Sales 2024 * 268M 286M Sales 2025 * 294M 314M Capitalization 756M 807M
Net income 2024 * 31M 33.09M Net income 2025 * 34M 36.3M EV / Sales 2024 * 2.67 x
Net cash position 2024 * 41.5M 44.3M Net cash position 2025 * 37.9M 40.46M EV / Sales 2025 * 2.44 x
P/E ratio 2024 *
24.2 x
P/E ratio 2025 *
21.7 x
Employees 1,075
Yield 2024 *
1.38%
Yield 2025 *
1.38%
Free-Float 66.95%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.62%
1 week+7.33%
Current month-2.14%
1 month-4.04%
3 months-17.31%
6 months+12.62%
Current year-11.47%
More quotes
1 week
32.50
Extreme 32.5
37.42
1 month
32.50
Extreme 32.5
38.16
Current year
32.50
Extreme 32.5
46.70
1 year
29.06
Extreme 29.06
50.00
3 years
29.06
Extreme 29.06
141.20
5 years
18.00
Extreme 18
141.20
10 years
4.12
Extreme 4.1228
141.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 16-12-31
Founder 55 96-12-31
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 71 18-12-31
Founder 55 96-12-31
Director/Board Member 71 19-05-28
More insiders
Date Price Change Volume
24-04-23 36.6 -1.35% 456
24-04-22 37.1 +12.56% 1,731
24-04-19 32.96 -1.61% 230
24-04-18 33.5 -0.48% 100
24-04-17 33.66 -1.29% 320

Delayed Quote Deutsche Boerse AG, April 23, 2024 at 03:39 am EDT

More quotes
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
36.3 EUR
Average target price
60 EUR
Spread / Average Target
+65.29%
Consensus

Annual profits - Rate of surprise